Kausik Datta

Dr. Kausik Datta

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2009 in Emerging Infectious Diseases
Verified
Journal Article
Open access
KDKausik Datta
Kausik Datta
KBKaren H. Bartlett
Karen H. Bartlett
RBRebecca Baer
Rebecca Baer
EBEdmond Byrnes
Edmond Byrnes
EGEleni Galanis
Eleni Galanis
FNfor the Cryptococcus gattii Working Group of the Pacific Northwest
for the Cryptococcus gattii Working Group of the Pacific Northwest
Cryptococcus gattii has emerged as a human and animal pathogen in the Pacific Northwest. First recognized on Vancouver Island, British Columbia, Canada, it now involves mainland British Columbia, and Washington and Oregon in the United States. In Canada, the incidence of disease has been one of the highest worldwide. In the United States, lack of cryptococcal species identification and case surveillance limit our knowledge of C. gattii epidemiology. Infections in the Pacific Northwest are caused by multiple genotypes, but the major strain is genetically novel and may have emerged recently in association with unique mating or environmental changes. C. gattii disease affects immunocompromised and immunocompetent persons, causing substantial illness and death. Successful management requires an aggressive medical and surgical approach and consideration of potentially variable antifungal drug susceptibilities. We summarize the study results of a group of investigators and review current knowledge with the goal of increasing awareness and highlighting areas where further knowledge is required.

1 September 2000 in Journal of Infection
Verified
Journal Article
Closed access
RGR. Goswami
R. Goswami
VDV. Dadhwal
V. Dadhwal
STS. Tejaswi
S. Tejaswi
KDKausik Datta
Kausik Datta
APA. Paul
A. Paul
NKN.P. Kochupillai
N.P. Kochupillai

15 May 2010 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
KSKrishanthi Subramaniam
Krishanthi Subramaniam
KDKausik Datta
Kausik Datta
EQEric Quintero
Eric Quintero
CMCatherine Manix
Catherine Manix
MMMatthew S. Marks
Matthew S. Marks
LPLiise-Anne Pirofski
Liise-Anne Pirofski
The importance of T cell-mediated immunity for resistance to the disease (cryptococcal disease) caused by Cryptococcus neoformans is incontrovertible, but whether Ab immunity also contributes to resistance remains uncertain. To investigate the role of IgM in resistance to C. neoformans, we compared the survival, fungal burden, lung and brain inflammatory responses, and lung phagocytic response of sIgM−/− mice, which lack secreted IgM, to that of IgM sufficient C57BL6x129Sv (heretofore, control) mice at different times after intranasal infection with C. neoformans (24067). sIgM−/− mice had higher mortality and higher blood and brain CFUs 28 d postinfection, but lung CFUs were comparable. Lungs of control mice manifested exuberant histiocytic inflammation with visible C. neoformans, findings that were not observed in sIgM−/− mice, whereas in brain sections, sIgM−/− mice had marked inflammation with visible C. neoformans that was not observed in control mice. Cytokine responses were significant for higher levels of lung IL-1β and IL-12 24 h postinfection in control mice and higher levels of lung and brain IL-17 28 d postinfection in sIgM−/− mice. Alveolar macrophage phagocytosis was significantly higher for control than for sIgM−/− mice 24 h postinfection; however, phagocytic indices of sIgM−/− mice increased after reconstitution of sIgM−/− mice with polyclonal IgM. These data establish a previously unrecognized role for IgM in resistance to intranasal infection with C. neoformans in mice and suggest that the mechanism by which it mediates a host benefit is by augmenting Th1 polarization, macrophage recruitment and phagocytosis of C. neoformans.

11 March 2019 in Clinical Infectious Diseases
Verified
Journal Article
Closed access
PDF file
KMKieren A Marr
Kieren A Marr
YSYifei Sun
Yifei Sun
ASAndrej Spec
Andrej Spec
NLNa Lu
Na Lu
APAnil Panackal
Anil Panackal
WPWilliam Powderly
William Powderly
Cryptococcosis is increasingly recognized in people without human immunodeficiency virus (HIV). A multicenter, prospective cohort study was performed in 25 US centers. Consenting patients were prospectively followed for ≤2 years. Neurological morbidities were assessed with longitudinal event depiction and functional scores (Montreal Cognitive Assessment [MoCA]). Risks of death were analyzed using Cox regression. One hundred forty-five subjects were enrolled. Most were male (95; 65.5%) and had immunosuppression (120; 82.8%), including solid organ transplant (SOT; 33.8%), autoimmunity (15.9%), and hematologic malignancies (11.7%). Disease involved the central nervous system (CNS) in 71 subjects (49%). Fever was uncommon, documented in 40 (27.8%) subjects, and absence was associated with diagnostic delay (mean: 48.2 vs 16.5 days; P = .007). Abnormal MoCA scores (<26) were predictive of CNS disease; low scores (1 lumbar puncture and 8 (11.3%) required ventriculostomies. In multivariable models, older age (>60 years) was associated with higher risks of death (hazard ratio [HR], 2.14; 95% confidence interval [CI], 1.05–4.38; P = .036), and lower risks were noted with underlying hematologic malignancy (HR, 0.29; 95% CI, 0.09–0.98; P = .05) and prior SOT (HR, 0.153; 95% CI, 0.05–0.44; P = .001). Despite aggressive antifungal therapies, outcomes of CNS cryptococcosis in people without HIV are characterized by substantial long-term neurological sequelae. Studies are needed to understand mechanism(s) of cognitive decline and to enable better treatment algorithms.

1 February 2012 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
NCNeelkamal Chaudhary
Neelkamal Chaudhary
KDKausik Datta
Kausik Datta
FAFrederic B. Askin
Frederic B. Askin
JSJanet F. Staab
Janet F. Staab
KMKieren A. Marr
Kieren A. Marr
Rationale: Mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) alter epithelial cell (EC) interactions with multiple microbes, such that dysregulated inflammation and injury occur with airway colonization in people with cystic fibrosis (CF). Aspergillus fumigatus frequently colonizes CF airways, but it has been assumed to be an innocent saprophyte; its potential role as a cause of lung disease is controversial. Objectives: To study the interactions between Aspergillus and EC, and the role of the fungus in evoking inflammatory responses. Methods: A. fumigatus expressing green fluorescent protein was developed for in vitro and in vivo models, which used cell lines and mouse tracheal EC. Measurements and Main Results: Fungal spores (conidia) are rapidly ingested by ECs derived from bronchial cell lines and murine tracheas, supporting a role for EC in early airway clearance. Bronchial ECs harboring CFTR mutations (ΔF508) or deletion demonstrate impaired uptake and killing of conidia, and ECs with CFTR mutation undergo more conidial-induced apoptosis. Germinated (hyphal) forms of the fungus evoke secretion of inflammatory mediators, with CFTR mutation resulting in increased airway levels of macrophage inflammatory protein 2 and KC, and higher lung monocyte chemotactic protein-1. After A. fumigatus inhalation, CFTR−/− mice develop exaggerated lymphocytic inflammation, mucin accumulation, and lung injury. Conclusions: Data demonstrate a critical role for CFTR in mediating EC responses to A. fumigatus. Results suggest that the fungus elicits aberrant pulmonary inflammation in the setting of CFTR mutation, supporting the potential role of antifungals to halt progressive CF lung disease.

1 December 2020 in The Journal of Molecular Diagnostics
Verified
Journal Article
Closed access
BLBaoming Liu
Baoming Liu
MTMarissa Totten
Marissa Totten
SNSaman Nematollahi
Saman Nematollahi
KDKausik Datta
Kausik Datta
WMWarda Memon
Warda Memon
SZSean Zhang
Sean Zhang